Literature DB >> 2310343

Trazodone-induced palinopsia.

M S Hughes1, S Lessell.   

Abstract

Palinopsia refers to the persistence or reappearance of an image of a recently viewed object. Typically, patients with palinopsia have other visual symptoms or signs, and the underlying cause is a structural lesion of the posterior portions of the cerebral hemispheres. However, we treated three patients who experienced palinopsia as an isolated symptom, apparently as a side effect of trazodone hydrochloride therapy for depression. The palinopsia was dose related and disappeared with reduction or cessation of therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310343     DOI: 10.1001/archopht.1990.01070050097040

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

Review 1.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

2.  Palinopsia from a posteriorly placed glioma--an insight into its possible causes.

Authors:  Amad Naseer Khan; Rakesh Sharma; Salema Khalid; David McKean; Richard Armstrong; Christopher Kennard
Journal:  BMJ Case Rep       Date:  2011-02-02

3.  Central and peripheral vision loss associated with nefazodone usage.

Authors:  Chi Luu; Patricia Kiely; David Crewther; Lionel Kowal; Sheila Crewther
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

Review 4.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

Review 5.  Visual Snow Syndrome: Proposed Criteria, Clinical Implications, and Pathophysiology.

Authors:  Abby I Metzler; Carrie E Robertson
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-22       Impact factor: 5.081

6.  Visual trails: do the doors of perception open periodically?

Authors:  Julien Dubois; Rufin Vanrullen
Journal:  PLoS Biol       Date:  2011-05-10       Impact factor: 8.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.